utahmedical8-k20111020.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): October 20, 2011


Commission File No. 001-12575


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


                                         UTAH                                            
                     87-0342734                    
(State or other jurisdiction of incorporation or organization)
 (I.R.S. Employer Identification No.)
   
   

7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:
(801) 566-1200

 
 
 
 
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the quarter and nine months ended September 30, 2011 and forward-looking statements relating to 2011 and beyond as presented in a press release dated October 20, 2011.  The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.


SIGNATURES


Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
   
   
Date:  10/20/2011
By:      /s/ Kevin L. Cornwell
 
Kevin L. Cornwell
 
CEO
   



EXHIBIT INDEX

Index
Number             Description

99.1
Financial information for Utah Medical Products, Inc. for the quarter and nine months ended September 30, 2011 and forward-looking statements relating to 2011 and beyond as presented in a press release dated October 20, 2011.